Omidenepag Promising Against Glaucoma in Real-World Study

by Medscape • 2025/06/25 • 0 Comments

Eye drops containing 0.002% omidenepag isopropyl can safely reduce intraocular pressure in patients with newly diagnosed primary open-angle glaucoma, according to a real-world study.
Medscape Medical News

← Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell

STAAR Surgical Announces Appointment of Deborah Andrews as Chief Financial Officer, Forms Capital Stewardship Committee of the Board of Directors →

Post navigation